{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001918","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2024-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.387917+00:00","generated_at":"2026-06-07T01:13:16.001910+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.15,"confidence":"high","headline":"AIM ImmunoTech shareholders reject advisory compensation vote; directors elected","bullets":["Four director nominees elected: Appelrouth (6.95M for), Bryan (10.52M), Equels (10.29M), Mitchell (6.68M).","Ratification of BDO USA as auditor passed: 18.18M for, 0.60M against, 1.63M abstain.","Non-binding advisory vote on executive compensation failed: 4.58M for, 7.32M against.","Frequency of compensation vote: 1 year selected with 10.46M votes; board set annual vote.","Broker non-votes of 7.98M on Proposals 1, 3, and 4."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001918","json":"https://secwatch.observer/filing/0001493152-24-001918.json","markdown":"https://secwatch.observer/filing/0001493152-24-001918.md","text":"https://secwatch.observer/filing/0001493152-24-001918.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315224001918/0001493152-24-001918-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315224001918/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:13:16.001910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ea72b7655f251fce3f6a091994734d80126b6af","claim":"AIM ImmunoTech Inc. shareholders rejected Approval, by non-binding advisory vote, of the compensation of the Company’s named executive officers at the 2024-01-05 meeting.","evidence_excerpt":"Proposal 3: Approval, by non-binding advisory vote, of the compensation of the Company’s named executive officers : For: 4,582,081 Against: 7,320,705 Abstain: 536,196","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224001918/0001493152-24-001918-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"failed"},{"label":"Meeting","value":"2024-01-05"}],"fact_type":"shareholder_vote"},{"claim_id":"499ed2b8f513589d246a41d2fef6f2579f961cda","claim":"AIM ImmunoTech Inc. shareholders approved Election of Directors at the 2024-01-05 meeting.","evidence_excerpt":"Proposal 1: Election of Directors : The following four director nominees were each elected to serve a term ending at the Company’s Annual Meeting of Stockholders for 2024, or until their successors are duly elected and qualified: Nominees For Withheld Stewart L. Appelrouth 6,952,332 5,486,650 Nancy K. Bryan 10,522,260 1,916,722 Thomas K. Equels 10,294,728 2,144,254 William M. Mitchell 6,677,727 5,761,255","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224001918/0001493152-24-001918-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-05"}],"fact_type":"shareholder_vote"},{"claim_id":"d10daa13a31b3ddf45e55961f6385d19a7af8733","claim":"AIM ImmunoTech Inc. shareholders approved Ratification of the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2024-01-05 meeting.","evidence_excerpt":"Proposal 2: Ratification of the selection of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 : For: 18,181,409 Against: 603,158 Abstain: 1,634,472","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224001918/0001493152-24-001918-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-05"}],"fact_type":"shareholder_vote"},{"claim_id":"e0c5db2192ad02f859584689894557feae448dd7","claim":"AIM ImmunoTech Inc. shareholders approved Approval, by non-binding advisory vote, of the frequency of executive compensation votes at the 2024-01-05 meeting.","evidence_excerpt":"Proposal 4: Approval, by non-binding advisory vote, of the frequency of executive compensation votes : 1 Year: 10,460,322 2 Years: 137,119 3 Years: 1,176,713 Abstain: 664,828 Based on the results of the vote, and consistent with the Board’s recommendation, the Board has determined to hold a non-binding advisory vote regarding executive compensation every year until the next required non-binding advisory vote on the frequency of holding future votes regarding executive compensation.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/946644/000149315224001918/0001493152-24-001918-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-05"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}